Review




Structured Review

Charles River Laboratories primary rat cortical neuron culture
DIV8 <t>primary</t> <t>rat</t> <t>cortical</t> <t>neurons</t> were treated with vehicle (Control, n = 4), 1 μM of SKF38393 (D1 dopamine receptor agonist, n = 4) and/or 10 nM of SCH23390 (D1 dopamine receptor antagonist n = 5) for 1.5 h. (A) Schematic shows hnRNP H and its quasi-RNA recognition motifs (qRRMs) and glycine-rich domains (GYR and GY). The red “Y” markings indicate the relative antibody epitopes in the N-domain or C-domain regions of hnRNP H. (B,C) ICC and intensity analysis revealed a significant increase in C-domain staining of nuclear hnRNP H following 1 μM SKF38393 [unpaired Student’s t-test, t6 = −4.94, *p = 0.003] that was blocked by co-administration of 1 μM SKF38393 and 10 nM SCH23390 [unpaired Student’s t-test, t7 = −0.34, p = 0.74]. (D) No significant difference was found in N-domain immunoreactivity of nuclear hnRNP H following 1 μM SKF38393 treatment [unpaired Student’s t-test, t6 = −1.12, p = 0.30]. (E) There was an effect of treatment on C-domain staining of hnRNP H [One-way ANOVA, F2,6 = 20.38, p < 0.001, n = 3 per condition]. SKF38393-induced increase in hnRNP H nuclear immunofluorescence was reduced in the present of the blocking peptide [post-hoc Bonferroni correction for Control vs SKF+blocking peptide: t4 = 5.849; *p = 0.004]. A significant increase in C-domain staining of nuclear hnRNP H following 1 μM SKF38393 [post-hoc Bonferroni correction for Control vs SKF: t4 = −3.454; *p = 0.025]. Black bar = Control; white bar = SKF treatment. Images were obtained on a Zeiss AxioObserver microscope with the 20X objective under uniform settings. Scale bars represent 40 μm.
Primary Rat Cortical Neuron Culture, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary rat cortical neuron culture/product/Charles River Laboratories
Average 90 stars, based on 1 article reviews
primary rat cortical neuron culture - by Bioz Stars, 2026-03
90/100 stars

Images

1) Product Images from "Changes in neuronal immunofluorescence in the C- versus N-terminal domains of hnRNP H following D1 dopamine receptor activation"

Article Title: Changes in neuronal immunofluorescence in the C- versus N-terminal domains of hnRNP H following D1 dopamine receptor activation

Journal: Neuroscience letters

doi: 10.1016/j.neulet.2018.07.015

DIV8 primary rat cortical neurons were treated with vehicle (Control, n = 4), 1 μM of SKF38393 (D1 dopamine receptor agonist, n = 4) and/or 10 nM of SCH23390 (D1 dopamine receptor antagonist n = 5) for 1.5 h. (A) Schematic shows hnRNP H and its quasi-RNA recognition motifs (qRRMs) and glycine-rich domains (GYR and GY). The red “Y” markings indicate the relative antibody epitopes in the N-domain or C-domain regions of hnRNP H. (B,C) ICC and intensity analysis revealed a significant increase in C-domain staining of nuclear hnRNP H following 1 μM SKF38393 [unpaired Student’s t-test, t6 = −4.94, *p = 0.003] that was blocked by co-administration of 1 μM SKF38393 and 10 nM SCH23390 [unpaired Student’s t-test, t7 = −0.34, p = 0.74]. (D) No significant difference was found in N-domain immunoreactivity of nuclear hnRNP H following 1 μM SKF38393 treatment [unpaired Student’s t-test, t6 = −1.12, p = 0.30]. (E) There was an effect of treatment on C-domain staining of hnRNP H [One-way ANOVA, F2,6 = 20.38, p < 0.001, n = 3 per condition]. SKF38393-induced increase in hnRNP H nuclear immunofluorescence was reduced in the present of the blocking peptide [post-hoc Bonferroni correction for Control vs SKF+blocking peptide: t4 = 5.849; *p = 0.004]. A significant increase in C-domain staining of nuclear hnRNP H following 1 μM SKF38393 [post-hoc Bonferroni correction for Control vs SKF: t4 = −3.454; *p = 0.025]. Black bar = Control; white bar = SKF treatment. Images were obtained on a Zeiss AxioObserver microscope with the 20X objective under uniform settings. Scale bars represent 40 μm.
Figure Legend Snippet: DIV8 primary rat cortical neurons were treated with vehicle (Control, n = 4), 1 μM of SKF38393 (D1 dopamine receptor agonist, n = 4) and/or 10 nM of SCH23390 (D1 dopamine receptor antagonist n = 5) for 1.5 h. (A) Schematic shows hnRNP H and its quasi-RNA recognition motifs (qRRMs) and glycine-rich domains (GYR and GY). The red “Y” markings indicate the relative antibody epitopes in the N-domain or C-domain regions of hnRNP H. (B,C) ICC and intensity analysis revealed a significant increase in C-domain staining of nuclear hnRNP H following 1 μM SKF38393 [unpaired Student’s t-test, t6 = −4.94, *p = 0.003] that was blocked by co-administration of 1 μM SKF38393 and 10 nM SCH23390 [unpaired Student’s t-test, t7 = −0.34, p = 0.74]. (D) No significant difference was found in N-domain immunoreactivity of nuclear hnRNP H following 1 μM SKF38393 treatment [unpaired Student’s t-test, t6 = −1.12, p = 0.30]. (E) There was an effect of treatment on C-domain staining of hnRNP H [One-way ANOVA, F2,6 = 20.38, p < 0.001, n = 3 per condition]. SKF38393-induced increase in hnRNP H nuclear immunofluorescence was reduced in the present of the blocking peptide [post-hoc Bonferroni correction for Control vs SKF+blocking peptide: t4 = 5.849; *p = 0.004]. A significant increase in C-domain staining of nuclear hnRNP H following 1 μM SKF38393 [post-hoc Bonferroni correction for Control vs SKF: t4 = −3.454; *p = 0.025]. Black bar = Control; white bar = SKF treatment. Images were obtained on a Zeiss AxioObserver microscope with the 20X objective under uniform settings. Scale bars represent 40 μm.

Techniques Used: Control, Staining, Immunofluorescence, Blocking Assay, Microscopy

DIV8 primary rat cortical neurons were treated with media (Control, n = 4) or 1 μM of SKF38393 (D1 dopamine receptor agonist, n = 4) for 1.5 h. (A) Schematic shows hnRNP H domains and the red “Y” marking indicates the relative antibody epitopes in the C-domain regions of hnRNP H. (B) Merged images showing co-localization of hnRNP H with NeuN (neuronal marker) and DAPI (nuclear marker). Images from individual channel are shown in Fig S5. hnRNP H staining was localized to the nucleus and no cytoplasmic localization of hnRNP H was detected. ICC and intensity analysis revealed a significant increase in C-domain staining of nuclear hnRNP H following 1 μM SKF38393 for NeuN-positive and hnRNP H-positive neurons (unpaired Student’s t-test, t6 = −5.58, *p < 0.01). (C) There was co-localized staining of hnRNP H with NeuN-positive neuronal staining and no detectable staining of hnRNP H staining in non-neuronal cells. No significant differences in percentage of NeuN/hnRNP H-positive cells [unpaired Student’s t-test, t6 = −0.052, p = 0.96] or non-NeuN cells [unpaired Student’s t-test, t6 = −0.052, p = 0.96] were noted between treatment conditions. Black bar = Control; white bar = SKF treatment. Images were obtained on a Zeiss AxioObserver microscope with the 63X objective under uniform settings. Scale bars represent 15 μm.
Figure Legend Snippet: DIV8 primary rat cortical neurons were treated with media (Control, n = 4) or 1 μM of SKF38393 (D1 dopamine receptor agonist, n = 4) for 1.5 h. (A) Schematic shows hnRNP H domains and the red “Y” marking indicates the relative antibody epitopes in the C-domain regions of hnRNP H. (B) Merged images showing co-localization of hnRNP H with NeuN (neuronal marker) and DAPI (nuclear marker). Images from individual channel are shown in Fig S5. hnRNP H staining was localized to the nucleus and no cytoplasmic localization of hnRNP H was detected. ICC and intensity analysis revealed a significant increase in C-domain staining of nuclear hnRNP H following 1 μM SKF38393 for NeuN-positive and hnRNP H-positive neurons (unpaired Student’s t-test, t6 = −5.58, *p < 0.01). (C) There was co-localized staining of hnRNP H with NeuN-positive neuronal staining and no detectable staining of hnRNP H staining in non-neuronal cells. No significant differences in percentage of NeuN/hnRNP H-positive cells [unpaired Student’s t-test, t6 = −0.052, p = 0.96] or non-NeuN cells [unpaired Student’s t-test, t6 = −0.052, p = 0.96] were noted between treatment conditions. Black bar = Control; white bar = SKF treatment. Images were obtained on a Zeiss AxioObserver microscope with the 63X objective under uniform settings. Scale bars represent 15 μm.

Techniques Used: Control, Marker, Staining, Microscopy

DIV8 primary rat cortical neurons were treated with vehicle (Control, n = 4) or 1 μM of SKF38393 (D1 dopamine receptor agonist, n = 4) for 1.5 h. (A) qPCR analysis revealed a small decrease in Hnrnph1 mRNA (top left) [Exon 4–5: unpaired Student’s t-test, t6 = 2.866, *p = 0.03; Exon13–15: unpaired Student’s t-test, t6 = 3.367, *p=0.02] or Hnrnph2 mRNA (top right) [unpaired Student’s t-test, t6 = 2.432, p = 0.051]. (B) Immunoblot analysis of fractionated samples indicated no significant change in hnRNP H protein levels in the nucleus (Nu) or cytoplasm (Cy), as detected by either C-domain (left) or N-domain (right) antibodies. Two-way ANOVA with Cellular Compartment and Treatment as factors revealed a significant effect of Cellular Compartment [C-domain: F(1,12) = 51.45, p = 1.13 × 10−5; N-domain: F(1,12) = 123.52, p = 1.13 × 10−7], no significant effect of Treatment [C-domain: F(1,12) = 1.06, p = 0.32; N-domain: F(1,12) = 4.11, p = 0.07], and no interaction [C-domain: F(1,12) = 0.26, p = 0.62; N-domain: F(1,12) = 2.66, p = 0.13]. Successful nuclear and cytoplasmic fractionation was confirmed by CREB and HSP90. For either C- and N-domain immunoblot study: Control: n = 4, 1 μM SKF38393: n = 4. Black bar = Control; white bar = SKF treatment.
Figure Legend Snippet: DIV8 primary rat cortical neurons were treated with vehicle (Control, n = 4) or 1 μM of SKF38393 (D1 dopamine receptor agonist, n = 4) for 1.5 h. (A) qPCR analysis revealed a small decrease in Hnrnph1 mRNA (top left) [Exon 4–5: unpaired Student’s t-test, t6 = 2.866, *p = 0.03; Exon13–15: unpaired Student’s t-test, t6 = 3.367, *p=0.02] or Hnrnph2 mRNA (top right) [unpaired Student’s t-test, t6 = 2.432, p = 0.051]. (B) Immunoblot analysis of fractionated samples indicated no significant change in hnRNP H protein levels in the nucleus (Nu) or cytoplasm (Cy), as detected by either C-domain (left) or N-domain (right) antibodies. Two-way ANOVA with Cellular Compartment and Treatment as factors revealed a significant effect of Cellular Compartment [C-domain: F(1,12) = 51.45, p = 1.13 × 10−5; N-domain: F(1,12) = 123.52, p = 1.13 × 10−7], no significant effect of Treatment [C-domain: F(1,12) = 1.06, p = 0.32; N-domain: F(1,12) = 4.11, p = 0.07], and no interaction [C-domain: F(1,12) = 0.26, p = 0.62; N-domain: F(1,12) = 2.66, p = 0.13]. Successful nuclear and cytoplasmic fractionation was confirmed by CREB and HSP90. For either C- and N-domain immunoblot study: Control: n = 4, 1 μM SKF38393: n = 4. Black bar = Control; white bar = SKF treatment.

Techniques Used: Control, Western Blot, Fractionation



Similar Products

90
Dawley Inc primary cultured sprague-dawley rat cortical neurons
Effects of lycopene in nervous system disorders.
Primary Cultured Sprague Dawley Rat Cortical Neurons, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary cultured sprague-dawley rat cortical neurons/product/Dawley Inc
Average 90 stars, based on 1 article reviews
primary cultured sprague-dawley rat cortical neurons - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dawley Inc primary cultured cortical neurons of sprague–dawley (sd) rats
Effects of lycopene in nervous system disorders.
Primary Cultured Cortical Neurons Of Sprague–Dawley (Sd) Rats, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary cultured cortical neurons of sprague–dawley (sd) rats/product/Dawley Inc
Average 90 stars, based on 1 article reviews
primary cultured cortical neurons of sprague–dawley (sd) rats - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
BrainBits LLC primary cultures rat cortical neurons
Effects of lycopene in nervous system disorders.
Primary Cultures Rat Cortical Neurons, supplied by BrainBits LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary cultures rat cortical neurons/product/BrainBits LLC
Average 90 stars, based on 1 article reviews
primary cultures rat cortical neurons - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dawley Inc primary rat cortical astrocyte and neuron culture
Effects of lycopene in nervous system disorders.
Primary Rat Cortical Astrocyte And Neuron Culture, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary rat cortical astrocyte and neuron culture/product/Dawley Inc
Average 90 stars, based on 1 article reviews
primary rat cortical astrocyte and neuron culture - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dawley Inc primary cultures of rat cortical neurons
Effects of lycopene in nervous system disorders.
Primary Cultures Of Rat Cortical Neurons, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary cultures of rat cortical neurons/product/Dawley Inc
Average 90 stars, based on 1 article reviews
primary cultures of rat cortical neurons - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Dawley Inc primary cultured sprague–dawley rat embryonic (e-16) cortical neurons
Effects of lycopene in nervous system disorders.
Primary Cultured Sprague–Dawley Rat Embryonic (E 16) Cortical Neurons, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary cultured sprague–dawley rat embryonic (e-16) cortical neurons/product/Dawley Inc
Average 90 stars, based on 1 article reviews
primary cultured sprague–dawley rat embryonic (e-16) cortical neurons - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Charles River Laboratories primary rat cortical neuron culture
DIV8 <t>primary</t> <t>rat</t> <t>cortical</t> <t>neurons</t> were treated with vehicle (Control, n = 4), 1 μM of SKF38393 (D1 dopamine receptor agonist, n = 4) and/or 10 nM of SCH23390 (D1 dopamine receptor antagonist n = 5) for 1.5 h. (A) Schematic shows hnRNP H and its quasi-RNA recognition motifs (qRRMs) and glycine-rich domains (GYR and GY). The red “Y” markings indicate the relative antibody epitopes in the N-domain or C-domain regions of hnRNP H. (B,C) ICC and intensity analysis revealed a significant increase in C-domain staining of nuclear hnRNP H following 1 μM SKF38393 [unpaired Student’s t-test, t6 = −4.94, *p = 0.003] that was blocked by co-administration of 1 μM SKF38393 and 10 nM SCH23390 [unpaired Student’s t-test, t7 = −0.34, p = 0.74]. (D) No significant difference was found in N-domain immunoreactivity of nuclear hnRNP H following 1 μM SKF38393 treatment [unpaired Student’s t-test, t6 = −1.12, p = 0.30]. (E) There was an effect of treatment on C-domain staining of hnRNP H [One-way ANOVA, F2,6 = 20.38, p < 0.001, n = 3 per condition]. SKF38393-induced increase in hnRNP H nuclear immunofluorescence was reduced in the present of the blocking peptide [post-hoc Bonferroni correction for Control vs SKF+blocking peptide: t4 = 5.849; *p = 0.004]. A significant increase in C-domain staining of nuclear hnRNP H following 1 μM SKF38393 [post-hoc Bonferroni correction for Control vs SKF: t4 = −3.454; *p = 0.025]. Black bar = Control; white bar = SKF treatment. Images were obtained on a Zeiss AxioObserver microscope with the 20X objective under uniform settings. Scale bars represent 40 μm.
Primary Rat Cortical Neuron Culture, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary rat cortical neuron culture/product/Charles River Laboratories
Average 90 stars, based on 1 article reviews
primary rat cortical neuron culture - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Charles River Laboratories long evans rat embryonic day 19–20 mixed cortical primary neuron culture
KEY RESOURCES TABLE
Long Evans Rat Embryonic Day 19–20 Mixed Cortical Primary Neuron Culture, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/long evans rat embryonic day 19–20 mixed cortical primary neuron culture/product/Charles River Laboratories
Average 90 stars, based on 1 article reviews
long evans rat embryonic day 19–20 mixed cortical primary neuron culture - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Effects of lycopene in nervous system disorders.

Journal: Nutrients

Article Title: The Importance of Antioxidant Activity for the Health-Promoting Effect of Lycopene

doi: 10.3390/nu15173821

Figure Lengend Snippet: Effects of lycopene in nervous system disorders.

Article Snippet: Alzheimer′s disease , Primary cultured Sprague-Dawley rat cortical neurons , 24 h , Lycopene dissolved in tetrahydrofuran containing 0.025% butylated hydroxytoluene, added to culture medium, concentration of lycopene: 0.1, 0.5, 1, 2 or 5 μM , 1. Decreased intracellular reactive oxygen species generation and mitochondria-derived superoxide production, , , , 2016 , [ ] .

Techniques: Activity Assay, Expressing, Translocation Assay, Clinical Proteomics, Transgenic Assay, Transfection, Concentration Assay, Membrane, Activation Assay, Cell Culture, Permeability, Injection, Phospho-proteomics, Protein-Protein interactions

DIV8 primary rat cortical neurons were treated with vehicle (Control, n = 4), 1 μM of SKF38393 (D1 dopamine receptor agonist, n = 4) and/or 10 nM of SCH23390 (D1 dopamine receptor antagonist n = 5) for 1.5 h. (A) Schematic shows hnRNP H and its quasi-RNA recognition motifs (qRRMs) and glycine-rich domains (GYR and GY). The red “Y” markings indicate the relative antibody epitopes in the N-domain or C-domain regions of hnRNP H. (B,C) ICC and intensity analysis revealed a significant increase in C-domain staining of nuclear hnRNP H following 1 μM SKF38393 [unpaired Student’s t-test, t6 = −4.94, *p = 0.003] that was blocked by co-administration of 1 μM SKF38393 and 10 nM SCH23390 [unpaired Student’s t-test, t7 = −0.34, p = 0.74]. (D) No significant difference was found in N-domain immunoreactivity of nuclear hnRNP H following 1 μM SKF38393 treatment [unpaired Student’s t-test, t6 = −1.12, p = 0.30]. (E) There was an effect of treatment on C-domain staining of hnRNP H [One-way ANOVA, F2,6 = 20.38, p < 0.001, n = 3 per condition]. SKF38393-induced increase in hnRNP H nuclear immunofluorescence was reduced in the present of the blocking peptide [post-hoc Bonferroni correction for Control vs SKF+blocking peptide: t4 = 5.849; *p = 0.004]. A significant increase in C-domain staining of nuclear hnRNP H following 1 μM SKF38393 [post-hoc Bonferroni correction for Control vs SKF: t4 = −3.454; *p = 0.025]. Black bar = Control; white bar = SKF treatment. Images were obtained on a Zeiss AxioObserver microscope with the 20X objective under uniform settings. Scale bars represent 40 μm.

Journal: Neuroscience letters

Article Title: Changes in neuronal immunofluorescence in the C- versus N-terminal domains of hnRNP H following D1 dopamine receptor activation

doi: 10.1016/j.neulet.2018.07.015

Figure Lengend Snippet: DIV8 primary rat cortical neurons were treated with vehicle (Control, n = 4), 1 μM of SKF38393 (D1 dopamine receptor agonist, n = 4) and/or 10 nM of SCH23390 (D1 dopamine receptor antagonist n = 5) for 1.5 h. (A) Schematic shows hnRNP H and its quasi-RNA recognition motifs (qRRMs) and glycine-rich domains (GYR and GY). The red “Y” markings indicate the relative antibody epitopes in the N-domain or C-domain regions of hnRNP H. (B,C) ICC and intensity analysis revealed a significant increase in C-domain staining of nuclear hnRNP H following 1 μM SKF38393 [unpaired Student’s t-test, t6 = −4.94, *p = 0.003] that was blocked by co-administration of 1 μM SKF38393 and 10 nM SCH23390 [unpaired Student’s t-test, t7 = −0.34, p = 0.74]. (D) No significant difference was found in N-domain immunoreactivity of nuclear hnRNP H following 1 μM SKF38393 treatment [unpaired Student’s t-test, t6 = −1.12, p = 0.30]. (E) There was an effect of treatment on C-domain staining of hnRNP H [One-way ANOVA, F2,6 = 20.38, p < 0.001, n = 3 per condition]. SKF38393-induced increase in hnRNP H nuclear immunofluorescence was reduced in the present of the blocking peptide [post-hoc Bonferroni correction for Control vs SKF+blocking peptide: t4 = 5.849; *p = 0.004]. A significant increase in C-domain staining of nuclear hnRNP H following 1 μM SKF38393 [post-hoc Bonferroni correction for Control vs SKF: t4 = −3.454; *p = 0.025]. Black bar = Control; white bar = SKF treatment. Images were obtained on a Zeiss AxioObserver microscope with the 20X objective under uniform settings. Scale bars represent 40 μm.

Article Snippet: Primary rat cortical neuron culture and neuronal treatment Primary rat cortical neurons were dissected from neocortex of E18 Sprague-Dawley embryos (Charles River Laboratories, Wilmington, MA, USA) and grown in media as described [ 19 ].

Techniques: Control, Staining, Immunofluorescence, Blocking Assay, Microscopy

DIV8 primary rat cortical neurons were treated with media (Control, n = 4) or 1 μM of SKF38393 (D1 dopamine receptor agonist, n = 4) for 1.5 h. (A) Schematic shows hnRNP H domains and the red “Y” marking indicates the relative antibody epitopes in the C-domain regions of hnRNP H. (B) Merged images showing co-localization of hnRNP H with NeuN (neuronal marker) and DAPI (nuclear marker). Images from individual channel are shown in Fig S5. hnRNP H staining was localized to the nucleus and no cytoplasmic localization of hnRNP H was detected. ICC and intensity analysis revealed a significant increase in C-domain staining of nuclear hnRNP H following 1 μM SKF38393 for NeuN-positive and hnRNP H-positive neurons (unpaired Student’s t-test, t6 = −5.58, *p < 0.01). (C) There was co-localized staining of hnRNP H with NeuN-positive neuronal staining and no detectable staining of hnRNP H staining in non-neuronal cells. No significant differences in percentage of NeuN/hnRNP H-positive cells [unpaired Student’s t-test, t6 = −0.052, p = 0.96] or non-NeuN cells [unpaired Student’s t-test, t6 = −0.052, p = 0.96] were noted between treatment conditions. Black bar = Control; white bar = SKF treatment. Images were obtained on a Zeiss AxioObserver microscope with the 63X objective under uniform settings. Scale bars represent 15 μm.

Journal: Neuroscience letters

Article Title: Changes in neuronal immunofluorescence in the C- versus N-terminal domains of hnRNP H following D1 dopamine receptor activation

doi: 10.1016/j.neulet.2018.07.015

Figure Lengend Snippet: DIV8 primary rat cortical neurons were treated with media (Control, n = 4) or 1 μM of SKF38393 (D1 dopamine receptor agonist, n = 4) for 1.5 h. (A) Schematic shows hnRNP H domains and the red “Y” marking indicates the relative antibody epitopes in the C-domain regions of hnRNP H. (B) Merged images showing co-localization of hnRNP H with NeuN (neuronal marker) and DAPI (nuclear marker). Images from individual channel are shown in Fig S5. hnRNP H staining was localized to the nucleus and no cytoplasmic localization of hnRNP H was detected. ICC and intensity analysis revealed a significant increase in C-domain staining of nuclear hnRNP H following 1 μM SKF38393 for NeuN-positive and hnRNP H-positive neurons (unpaired Student’s t-test, t6 = −5.58, *p < 0.01). (C) There was co-localized staining of hnRNP H with NeuN-positive neuronal staining and no detectable staining of hnRNP H staining in non-neuronal cells. No significant differences in percentage of NeuN/hnRNP H-positive cells [unpaired Student’s t-test, t6 = −0.052, p = 0.96] or non-NeuN cells [unpaired Student’s t-test, t6 = −0.052, p = 0.96] were noted between treatment conditions. Black bar = Control; white bar = SKF treatment. Images were obtained on a Zeiss AxioObserver microscope with the 63X objective under uniform settings. Scale bars represent 15 μm.

Article Snippet: Primary rat cortical neuron culture and neuronal treatment Primary rat cortical neurons were dissected from neocortex of E18 Sprague-Dawley embryos (Charles River Laboratories, Wilmington, MA, USA) and grown in media as described [ 19 ].

Techniques: Control, Marker, Staining, Microscopy

DIV8 primary rat cortical neurons were treated with vehicle (Control, n = 4) or 1 μM of SKF38393 (D1 dopamine receptor agonist, n = 4) for 1.5 h. (A) qPCR analysis revealed a small decrease in Hnrnph1 mRNA (top left) [Exon 4–5: unpaired Student’s t-test, t6 = 2.866, *p = 0.03; Exon13–15: unpaired Student’s t-test, t6 = 3.367, *p=0.02] or Hnrnph2 mRNA (top right) [unpaired Student’s t-test, t6 = 2.432, p = 0.051]. (B) Immunoblot analysis of fractionated samples indicated no significant change in hnRNP H protein levels in the nucleus (Nu) or cytoplasm (Cy), as detected by either C-domain (left) or N-domain (right) antibodies. Two-way ANOVA with Cellular Compartment and Treatment as factors revealed a significant effect of Cellular Compartment [C-domain: F(1,12) = 51.45, p = 1.13 × 10−5; N-domain: F(1,12) = 123.52, p = 1.13 × 10−7], no significant effect of Treatment [C-domain: F(1,12) = 1.06, p = 0.32; N-domain: F(1,12) = 4.11, p = 0.07], and no interaction [C-domain: F(1,12) = 0.26, p = 0.62; N-domain: F(1,12) = 2.66, p = 0.13]. Successful nuclear and cytoplasmic fractionation was confirmed by CREB and HSP90. For either C- and N-domain immunoblot study: Control: n = 4, 1 μM SKF38393: n = 4. Black bar = Control; white bar = SKF treatment.

Journal: Neuroscience letters

Article Title: Changes in neuronal immunofluorescence in the C- versus N-terminal domains of hnRNP H following D1 dopamine receptor activation

doi: 10.1016/j.neulet.2018.07.015

Figure Lengend Snippet: DIV8 primary rat cortical neurons were treated with vehicle (Control, n = 4) or 1 μM of SKF38393 (D1 dopamine receptor agonist, n = 4) for 1.5 h. (A) qPCR analysis revealed a small decrease in Hnrnph1 mRNA (top left) [Exon 4–5: unpaired Student’s t-test, t6 = 2.866, *p = 0.03; Exon13–15: unpaired Student’s t-test, t6 = 3.367, *p=0.02] or Hnrnph2 mRNA (top right) [unpaired Student’s t-test, t6 = 2.432, p = 0.051]. (B) Immunoblot analysis of fractionated samples indicated no significant change in hnRNP H protein levels in the nucleus (Nu) or cytoplasm (Cy), as detected by either C-domain (left) or N-domain (right) antibodies. Two-way ANOVA with Cellular Compartment and Treatment as factors revealed a significant effect of Cellular Compartment [C-domain: F(1,12) = 51.45, p = 1.13 × 10−5; N-domain: F(1,12) = 123.52, p = 1.13 × 10−7], no significant effect of Treatment [C-domain: F(1,12) = 1.06, p = 0.32; N-domain: F(1,12) = 4.11, p = 0.07], and no interaction [C-domain: F(1,12) = 0.26, p = 0.62; N-domain: F(1,12) = 2.66, p = 0.13]. Successful nuclear and cytoplasmic fractionation was confirmed by CREB and HSP90. For either C- and N-domain immunoblot study: Control: n = 4, 1 μM SKF38393: n = 4. Black bar = Control; white bar = SKF treatment.

Article Snippet: Primary rat cortical neuron culture and neuronal treatment Primary rat cortical neurons were dissected from neocortex of E18 Sprague-Dawley embryos (Charles River Laboratories, Wilmington, MA, USA) and grown in media as described [ 19 ].

Techniques: Control, Western Blot, Fractionation

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: An Intramolecular Salt Bridge Linking TDP43 RNA Binding, Protein Stability, and TDP43-Dependent Neurodegeneration

doi: 10.1016/j.celrep.2019.03.093

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Long Evans rat embryonic day 19–20 mixed cortical primary neuron culture , Charles River Co. , Strain Code: 006.

Techniques: Recombinant, Cloning, Mutagenesis, Labeling, Plasmid Preparation, Software, Fractionation